4//SEC Filing
Mohideen Pharis 4
Accession 0001209191-23-045641
CIK 0001613780other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 4:32 PM ET
Size
16.5 KB
Accession
0001209191-23-045641
Insider Transaction Report
Form 4
Mohideen Pharis
Chief Medical Officer
Transactions
- Award
Ordinary Shares
2022-11-21+17,500→ 51,700 total - Sale
Ordinary Shares
2022-11-24$2.88/sh−1,792$5,161→ 49,908 total - Sale
Ordinary Shares
2023-05-24$3.54/sh−469$1,660→ 49,439 total - Award
Employee Stock Option (right to buy)
2022-07-29+100,000→ 100,000 totalExercise: $4.83Exp: 2032-07-29→ Ordinary Shares (100,000 underlying) - Award
Employee Stock Option (right to buy)
2022-11-21+115,000→ 115,000 totalExercise: $3.07Exp: 2032-11-21→ Ordinary Shares (115,000 underlying) - Award
Ordinary Shares
2022-07-29+10,000→ 34,200 total
Footnotes (10)
- [F1]The ordinary shares may be represented by American Depositary Shares, each of which currently represents one-half of one ordinary share.
- [F10]25% of the shares subject to the option vest on November 21, 2023, with the remaining shares vesting in six equal semi-annual installments thereafter, subject to the Reporting Person continuing to provide service through each such date.
- [F2]Represents the Issuer's ordinary shares underlying a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one ordinary share. 25% of the shares underlying the RSU vest on July 29, 2023, with the remaining shares vesting in six equal semi-annual installments thereafter, subject in each case to the Reporting Person continuing to provide service through each such date.
- [F3]Represents the Issuer's ordinary shares underlying a restricted stock unit RSU award. Each RSU represents a contingent right to receive one ordinary share. 25% of the shares underlying the RSU vest on November 21, 2023, with the remaining shares vesting in six equal semi-annual installments thereafter, subject in each case to the Reporting Person continuing to provide service through each such date.
- [F4]Shares sold to satisfy withholding tax obligations upon the the vesting of RSUs.
- [F5]This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0409 to EURO 1.00 as of November 24, 2022.
- [F6]This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0746 to EURO 1.00 as of May 24, 2023.
- [F7]This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0226 to EURO 1.00 as of July 29, 2022.
- [F8]25% of the shares subject to the option vest on July 29, 2023, with the remaining shares vesting in six equal semi-annual installments thereafter, subject to the Reporting Person continuing to provide service through each such date.
- [F9]This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0242 to EURO 1.00 as of November 21, 2022.
Documents
Issuer
DBV Technologies S.A.
CIK 0001613780
Entity typeother
Related Parties
1- filerCIK 0001760395
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 4:32 PM ET
- Size
- 16.5 KB